JPMorgan reinstated coverage of Pacs Group (PACS) with an Overweight rating and $44 price target following a period of restriction. The firm believes Pacs has an attractive business model centered around acquiring underperforming skilled nursing facilities and capturing earnings through improvements to clinical, operational, and financial performance.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACS:
- Buy Recommendation for PACS Group Inc.: Strategic Expansion in Skilled Nursing Facilities with Strong Growth Potential
- Pacs Group price target raised to $40 from $32 at Truist
- Pacs Group management to meet with Truist
- Pacs Group names Kelly Priegnitz chief compliance officer
- Pacs Group announces business update